We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 529

Reverse Payment PTAB Settlements in BioPharma?
  • Oblon
  • USA
  • July 28 2016

Print Anti-Competitive IPR Settlements for Orange Book Patents? The Patent Trial & Appeal Board (PTAB) has the power to terminate an Inter Partes


PTAB Institution is Not Akin to Rejection in Patent Examination
  • Oblon
  • USA
  • July 26 2016

In patent examination, once a prima facie case of obviousness is presented in a rejection by the agency, the burden of production switches to the


USPTO Shares PTAB Trial Information with Patent Examiners
  • Oblon
  • USA
  • July 21 2016

Post Grant Outcomes is an Enhanced Patent Quality Initiative (EPQI) designed to develop a process for providing post grant information from sources


Proposed PTAB Fee Increases Delayed
  • Oblon
  • USA
  • July 14 2016

The USPTO proposed its first ever fee increase under the fee setting authority of the America Invents Act (AIA) in November of 2015. At the time, the


New Panel Hearing Option for After Final Patent Practice
  • Oblon
  • USA
  • July 11 2016

While not directly related to Patent Trial & Appeal Board (PTAB) practice, today, the USPTO announced the launch of the "Post-Prosecution Pilot


PTAB To Debut New E-Filing System July 9th
  • Oblon
  • USA
  • July 5 2016

In the rush to develop an e-filing system in the months ahead of September 16, 2012, the USPTO deployed a serviceable e-filing system for AIA trial


PTAB Seeks Patent Attorney Law Clerks
  • Oblon
  • USA
  • June 28 2016

As announced a few weeks back, the Patent Trial & Appeal Board (PTAB) will be taking on a limited number of law clerks. The posting on USA Jobs


Did Cuozzo Unravel Versata CBM Reviewability?
  • Oblon
  • USA
  • June 22 2016

In Cuozzo Speed Technologies, LLC v. Lee, the Supreme Court unanimously upheld the use of the broadest reasonable interpretation (BRI) of patent


BioSimilar Battle Expands at PTAB
  • Oblon
  • USA
  • June 20 2016

As discussed previously, biosimilar applicants can gain significant strategic advantage by availing themselves of Patent Trial & Appeal Board (PTAB


CAFC Makes Clear New Evidence During AIA Trials is Expected
  • Oblon
  • USA
  • June 16 2016

Within the past week, the Court of Appeals for the Federal Circuit (CAFC) has issued two significant opinions on AIA trial practiceboth of which